the underlying diseases in the 56 patients included in the evaluation of efficacy were acute myelocytic leukemia ( 24 cases ) , acute lymphocytic leukemia ( 8 ) , acute promyelocytic leukemia ( 6 ) , acute monomyelocytic leukemia ( 4 ) , acute monocytic leukemia ( 1 ) , erythroleukemia ( 1 ) , chronic myelocytic leukemia-blastic crisis ( 4 ) , malignant lymphoma ( 3 ) , aplastic anemia ( 2 ) , and others ( 3 ) .
C0023467
acute myelocytic
C0023487
acute promyelocytic